Menu

The Brain-Microbiome Axis: Links Between Neurological Disease and Microbiota

The Scientist will be exploring the connection between the human microbiome and the human brain.

Jun 2, 2018
The Scientist Creative Services Team

The Brain-Microbiome Axis: Links Between Neurological Disease and Microbiota from thescientistllc on Vimeo.

The human microbiome consists of trillions of commensal microbes. These include bacteria, fungi, and viruses, which naturally reside within the human body and have been documented to affect epigenetic mechanisms, metabolic activity, and immune system function. Researchers are now focusing on how microbiome perturbations impact human health and disease. In particular, certain gut microbiota profiles have been strongly linked to the development of neurological disorders, including autism spectrum disorder, schizophrenia, stress, and depression. For a more detailed look at how our resident microbes impact our brains, as well as how microbiome manipulation may open potential therapeutic avenues for these disorders, The Scientist is bringing together a panel of experts who will share their research, summarize the state of the science, and discuss the next steps for those looking to adopt the technique. Attendees will have the opportunity to interact with experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • How resident microbiota can influence the neurological health of their host
  • Whether microbiome composition can alter the course of human neurological disease

Meet the Speakers:

Jane Foster, PhD
Associate Professor
Department of Psychiatry & Behavioral Neurosciences
McMaster University

 

Helen Tremlett, PhD
Professor
Canada Research Chair in Neuroepidemiology and Multiple Sclerosis
Djavad Mowafaghian Centre for Brain Health
Faculty of Medicine (Neurology)
University of British Columbia Hospital

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!